Tag: Alzheimers
Biogen: FDA approval for Alzheimer’s disease
(CercleFinance.com) – Eisai and Biogen have announced that the FDA has granted traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer’s disease. ‘ The United States Food and Drug…
US expands access to promising new Alzheimer’s treatment
The American health authorities have fully authorized Thursday, July 6 a new treatment against Alzheimer’s, thus making it more accessible via the federal health insurance system. Leqembi, which aims to…
Alzheimer’s: this phone test could help with its diagnosis: Femme Actuelle Le MAG
Alzheimer’s: this phone test could help with its diagnosis: Femme Actuelle Le MAG Path 2 645DBCB3-7979-441A-BA4B-98E7BF17E1BE 1785B508-2A96-4CF5-AA87-79B0FE0441BF advertisement source site-44
Sleep apnea, a risk factor for Alzheimer’s disease?
A study published in the journal “Neurology” establishes an association between sleep apnea and dementia, without however proving that this disorder causes a decrease in brain volume. By Johanna Amselem…
Alzheimer’s, Parkinson’s, asthma: what if we could detect illnesses using the voice? : Current Woman Le MAG
Alzheimer’s, Parkinson’s, asthma: what if we could detect illnesses using the voice? : Current Woman Le MAG Path 2 645DBCB3-7979-441A-BA4B-98E7BF17E1BE 1785B508-2A96-4CF5-AA87-79B0FE0441BF advertisement source site-44
Could the retina of the eyes make it possible to detect Alzheimer’s disease prematurely?
Yasmina Kattou 09:54, March 30, 2023 Research to detect Alzheimer’s disease is progressing. American researchers have found a way to detect the disease prematurely through the eyes of patients, as…
Alzheimer’s: Roche joins forces with Lilly to improve early diagnosis of the disease – 03/22/2023 at 10:58
(AOF) – The Swiss pharmaceutical group Roche and its American counterpart Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (EAPP), a blood test aimed at…
The United States authorizes a long-awaited new treatment for Alzheimer’s
US health authorities on Friday authorized a new Alzheimer’s drug aimed at reducing cognitive decline in patients suffering from this neurodegenerative disease, a much-awaited treatment after the failed launch of…
New drugs for Alzheimer’s: what they do
The American regulatory authority FDA has again approved a drug for Alzheimer’s. This could also be available in Europe in 2023. We answer the most important questions about the medication.…
Alzheimer’s: researchers are developing a test that could revolutionize the detection of the disease
Florent Lanne December 29, 2022 at 11:30 a.m. 12 © Anna Shvets / Pexels Scientists have developed a blood test capable of detecting Alzheimer’s disease. This is neither more nor…
Roche: FDA authorization for Alzheimer’s tests
(CercleFinance.com) – Roche today announced that its Elecsys ® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys ® Phospho -Tau (181P) CSF (pTau181) test products have received regulatory approval. United States…
Drug against Alzheimer’s – Alzheimer’s research: A little bit of progress – knowledge
contents A new Alzheimer’s drug raises hopes that the disease can be slowed down at an early stage. But the drug can have serious side effects. Will there be an…